Back to search
FDAFDA · Food and drugs·Recall number D-1191-2018

Tizanidine HCl Tablets, USP 2mg, 150-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited Srilakulam - 532 409 INDIA, NDC 55111-179-15, UPC 35511179153

Published September 26, 2018 · Recall initiated: September 4, 2018

Summary

FDA records drug Class II recall D-1191-2018, published September 26, 2018 and initiated September 4, 2018. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 8376 units; Lot: Lot #: T800304, Exp. 03/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tablets .

What to do

Voluntary: Firm initiated · Letter

Get an email if TIZANIDINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TIZANIDINE
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide within the United States
UPC
0355111180104
Lot
Lot #: T800304, Exp. 03/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tizanidine HCl Tablets, USP 2mg, 150-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited Srilakulam - 532 409 INDIA, NDC 55111-179-15, UPC 35511179153 recalled?

Yes. FDA published recall D-1191-2018 on September 26, 2018. Reported hazard: Presence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tablets .

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TIZANIDINE. UPC: 0355111180104.